Novel Compounds as SARS-CoV-2-Related 3C-Like Protease Inhibitors for Treating Coronavirus Infections

ACS Medicinal Chemistry Letters 2026 Open access

Read full text
Authors: Ram W. Sabnis
DOI: 10.1021/acsmedchemlett.6c00356
Cited by: 1
References: 6

Abstract

Abstract Provided herein are novel compounds as SARS-CoV-2-related 3C-like protease (3CLPRO) inhibitors, pharmaceutical compositions, use of such compounds in treating coronavirus infections, and processes for preparing such compounds.

Fields of Study & Subjects

Diverse Scientific Research Studies Computational Drug Discovery Methods Pharmacological Receptor Mechanisms and Effects

Publication details

Journal / source
ACS Medicinal Chemistry Letters
Publisher
American Chemical Society (ACS)
Volume
17
Issue
8
Pages
1703–1704
Publication date
13 July 2026
Language
EN